Erlotinib vs Spironolactone

Erlotinib vs Spironolactone: Overview

This comparison examines the pharmacological differences between Erlotinib and Spironolactone.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Spironolactone — 1.4 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Spironolactone — C24H32O4S.

Molecular Weight: Erlotinib — 393.4380 g/mol; Spironolactone — 416.5740 g/mol.

Type: Erlotinib — Small molecule; Spironolactone — Small molecule.